Ostatní
Návod 
argenx SE
ARGX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
52.8B
Obrat
5B
Zisk
2B
Aktiva
7B
Dluh
0B
ROE
23%
ROA
19%
PE
20
PS
8
Cena 1R
510-935
⌀ Cena
706.34
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Argenx SE, biotechnologická společnost, se zaměřuje na vývoj různých terapií pro léčbu autoimunitních onemocnění ve Spojených státech, Nizozemsku, Belgii, Japonsku, Švýcarsku, Německu a Francii. Hlavním kandidátem přípravku je efgartigimod určený k léčbě pacientů s myasthenia gravis, imunitní trombocytopenií, pemphigus vulgaris a chronickou zánětlivou demyelinizační polyneuropatií ve fázi III klinických studií; bulózní pemfigoidní a idiopatická zánětlivá myopatie ve fázi II/III klinických studií; a ENHANZE SC v předklinické studii. Společnost také vyvíjí imunologické inovační programy, včetně kukukumabu pro hematologický karcinom, stejně jako vysoce rizikové MDS; ARGX-119, protilátky, která cílí na stadium tyrosinkinázy specifické pro svalstvo; ARGX-117 pro závažné autoimunitní indikace; ARGX-118 pro zánět dýchacích cest; a ARGX-120 pro léčbu autoimunitních onemocnění. Mezi jeho partnerské produkty patří ARGX-115 pro léčbu rakoviny, ARGX-112 pro léčbu receptoru interleukinu-22 a ARGX-114, protilátka namířená proti receptoru MET. Společnost má strategické partnerství se společnostmi AbbVie S.À.R.L., Zai Lab Limited a LEO Pharma A/S; a spolupráci a licenční smlouvu s Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V. a Shire International Společnost GmbH. argenx SE byla založena v roce 2008 a sídlí v nizozemském Bredě.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
1599
Založení
2017-05-18
Podobné společnosti
$ 177.84
- $ 0.07
$ 83.48
+ $ 0.09
$ 447.69
+ $ 4.99
$ 294.08
- $ 0.79
$ 660.00
+ $ 2.47
$ 202.89
- $ 0.78
$ 146.16
- $ 0.58
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 5,491.3 | 4,164.2 | 2,190.2 | 1,226.3 | 410.7 | 497.3 | 44.8 | 78.2 | 24.6 | 43.7 | 15.5 | 7.5 | 4.6 | 3.7 | 2.2 | 1.5 | |
| Cost of Revenues | 1,114.9 | 452.1 | 227.3 | 117.8 | 29.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | |
| Gross Profit | 4,376.4 | 3,712.1 | 1,962.9 | 1,108.5 | 381.3 | 497.3 | 44.8 | 78.2 | 24.6 | 43.7 | 15.5 | 7.5 | 4.6 | 2.7 | 2.2 | 1.5 |
| Revenue | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2,406.4 | 948.0 | 790.7 | 1,346.3 | 573.2 | 901.9 | 401.0 | 407.4 | 329.8 | 270.6 | |
| Cost of Revenues | 258.4 | 110.7 | 80.8 | 664.9 | 59.1 | -437.6 | 43.2 | 143.0 | 36.0 | 24.0 | |
| Gross Profit | 2,147.9 | 837.2 | 709.9 | 681.4 | 514.2 | 1,281.6 | 357.8 | 264.4 | 293.8 | 246.5 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 755.1 | 663.4 | 580.5 | 400.3 | 221.4 | 95.6 | 62.1 | 33.2 | 22.6 | 15.4 | 12.9 | 14.6 | 6.3 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 709.5 | 472.1 | 307.6 | 183.7 | 72.3 | 31.4 | 14.9 | 7.4 | 5.4 | 4.2 | 2.9 | 2.7 | 2.5 | |
| Depreciation & Amortization | 22.3 | 0.0 | 17.5 | 111.5 | 27.0 | 50.1 | 1.1 | 17.3 | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | |
| Total Operating Expenses | 3,259.2 | 2,739.6 | 1,984.6 | 1,533.5 | 1,101.0 | 846.0 | 561.8 | 279.4 | 118.2 | 71.2 | 38.0 | 24.6 | 17.6 | 12.3 | 15.5 | 6.2 | |
| Operating Income | 1,115.8 | 972.5 | -21.7 | -425.0 | -719.7 | -348.7 | -513.8 | -200.0 | -93.6 | -27.5 | -22.5 | -17.1 | -13.1 | -8.6 | -13.3 | -4.7 |
| Operating Income | TTM | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 204.6 | 191.8 | 195.5 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 207.8 | 191.9 | 160.9 | ||
| Depreciation & Amortization | 0.0 | 13.4 | 0.0 | 8.9 | 0.0 | 8.6 | 0.0 | 103.5 | 23.8 | 4.6 | ||
| Total Operating Expenses | 1,489.4 | 636.2 | 570.9 | 562.7 | 500.0 | 495.0 | 451.2 | 412.5 | 373.6 | 347.0 | ||
| Operating Income | 658.6 | 201.1 | 138.9 | 117.2 | 14.2 | -138.9 | -93.4 | -148.1 | -80.6 | -102.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 183.2 | 163.6 | 138.5 | 93.0 | 27.7 | 3.5 | 0.0 | 16.1 | 4.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.3 | 0.5 | 0.2 | |
| Interest Expense | 4.8 | 4.1 | 2.2 | 0.9 | 3.9 | 1.1 | 1.7 | 0.1 | -35.0 | 5.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 335.3 | 310.1 | 106.8 | 120.6 | -9.7 | -51.0 | -133.3 | 22.8 | 14.1 | -5.7 | 0.0 | 0.2 | 0.4 | -0.1 | 0.0 | 0.0 | |
| IBT | 1,451.1 | 1,282.6 | 85.2 | -304.5 | -729.3 | -399.7 | -647.1 | -177.2 | -75.3 | -33.0 | -22.5 | -16.7 | -12.5 | -8.5 | -12.8 | -4.5 | |
| Income Tax Expense | -700.9 | -13.5 | -747.9 | -9.4 | -19.7 | 8.5 | 3.4 | 5.3 | 0.9 | 0.7 | 0.0 | -0.2 | -0.4 | 0.1 | 0.0 | 0.0 | |
| Net Income | 2,155.3 | 1,296.0 | 833.0 | -295.1 | -709.6 | -408.3 | -650.5 | -182.5 | -76.2 | -33.7 | -22.5 | -16.7 | -12.5 | -8.5 | -12.8 | -4.5 |
| Net Income | TTM | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 87.3 | 38.4 | 37.1 | 20.3 | 40.6 | 38.9 | 38.9 | 40.4 | 30.0 | 20.4 | ||
| Interest Expense | 1.8 | 1.1 | 1.1 | 0.7 | 0.7 | 0.6 | 0.5 | 0.3 | 0.2 | 0.2 | ||
| Other Expense | 128.7 | 85.8 | 63.4 | 57.3 | 73.8 | 49.5 | 19.1 | 86.9 | -2.7 | 18.2 | ||
| IBT | 787.3 | 286.9 | 202.4 | 174.5 | 88.0 | -89.4 | -74.4 | -59.5 | -83.3 | -83.9 | ||
| Income Tax Expense | -87.6 | 41.5 | 32.9 | -687.7 | -3.4 | -56.8 | -12.8 | 38.0 | -10.6 | 10.5 | ||
| Net Income | 874.9 | 245.4 | 169.5 | 865.6 | 91.4 | -32.5 | -61.6 | -99.3 | -72.6 | -94.4 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-5.16 | $-13.05 | $-7.99 | $-0.01 | $-4.73 | $-2.12 | $-1.37 | $-1.19 | $-1.06 | $-1.66 | $-0.54 | $-0.82 | $-0.29 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-5.16 | $-13.05 | $-7.99 | $-0.01 | $-4.73 | $-2.12 | $-1.37 | $-1.19 | $-1.06 | $-1.66 | $-0.54 | $-0.82 | $-0.29 | |
| Shares Outstanding | 61.4 | 61.3 | 59.9 | 57.2 | 54.4 | 51.1 | 45,410.4 | 38.6 | 36.0 | 24.6 | 18.8 | 15.7 | 7.6 | 15.7 | 15.7 | 15.7 | |
| Diluted Shares Outstanding | 66.2 | 66.0 | 65.2 | 57.2 | 54.4 | 51.1 | 45,410.4 | 38.6 | 36.0 | 24.6 | 18.8 | 15.7 | 7.6 | 15.7 | 15.7 | 15.7 |
| Per Share Data | TTM | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.70 | $-1.25 | $-1.69 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.70 | $-1.25 | $-1.69 | ||
| Shares Outstanding | 61.4 | 61.0 | 61.0 | 59.8 | 60.1 | 59.4 | 59.3 | 58.3 | 58.1 | 55.7 | ||
| Diluted Shares Outstanding | 66.2 | 65.7 | 65.7 | 71.0 | 65.8 | 59.4 | 59.3 | 58.3 | 58.1 | 55.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,438.2 | 1,447.9 | 2,048.8 | 800.7 | 1,334.7 | 1,219.6 | 371.1 | 321.5 | 229.0 | 94.5 | 38.8 | 39.1 | 31.4 | 20.4 | 30.5 | 10.5 | |
| Short Term Investments | 1,664.1 | 1,878.9 | 1,131.0 | 1,391.8 | 1,002.1 | 781.5 | 1,125.3 | 324.3 | 202.6 | 7.2 | 7.4 | 28.9 | 0.7 | 1.4 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 3,102.3 | 3,378.8 | 3,179.8 | 2,192.5 | 2,336.7 | 2,001.1 | 1,496.3 | 645.8 | 431.6 | 101.7 | 46.3 | 68.1 | 32.1 | 21.8 | 30.5 | 10.5 | |
| Accounts Receivable | 655.6 | 909.1 | 499.3 | 277.3 | 38.2 | 7.5 | 31.8 | 3.6 | 3.6 | 2.2 | 1.5 | 1.6 | 1.5 | 0.6 | 1.0 | 1.4 | |
| Inventory | 326.5 | 407.2 | 310.6 | 228.4 | 109.1 | 25.3 | -1,023.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Other Current Assets | 179.4 | 18.5 | 134.1 | 0.0 | 58.9 | 28.0 | 1,033.1 | 5.4 | 4.8 | 3.1 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Current Assets | 4,263.8 | 4,713.7 | 4,123.7 | 2,774.2 | 2,543.0 | 2,061.8 | 1,538.2 | 654.8 | 440.1 | 107.1 | 48.3 | 69.8 | 33.7 | 22.5 | 31.6 | 11.9 |
| Current Assets | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | 2-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 2,086.0 | 1,447.9 | 1,438.2 | -2,946.8 | 2,048.8 | -1,888.9 | 1,110.6 | -2,021.3 | 800.7 | 1,367.3 | |
| Short Term Investments | 1,842.2 | 1,878.9 | 1,664.1 | 5,893.5 | 1,131.0 | 3,777.9 | 886.4 | 4,042.6 | 1,391.8 | 1,230.1 | |
| Total Cash & ST Investments | 3,928.2 | 3,378.8 | 3,102.3 | 2,946.8 | 3,179.8 | 1,888.9 | 1,997.0 | 2,021.3 | 2,192.5 | 2,597.4 | |
| Accounts Receivable | 1,198.2 | 909.1 | 655.6 | 0.0 | 378.6 | 0.0 | 278.8 | 0.0 | 277.3 | 113.9 | |
| Inventory | 340.6 | 407.2 | 326.5 | 0.0 | 310.6 | 0.0 | 201.1 | 0.0 | 228.4 | 135.7 | |
| Other Current Assets | 362.7 | 18.5 | 179.4 | 0.0 | 554.3 | 0.0 | 381.6 | 0.0 | 0.0 | 82.3 | |
| Total Current Assets | 5,829.7 | 4,713.7 | 4,263.8 | 2,946.8 | 4,123.7 | 1,888.9 | 2,691.5 | 2,021.3 | 2,774.2 | 2,929.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 36.9 | 43.5 | 22.7 | 16.2 | 15.8 | 11.7 | 9.1 | 0.9 | 0.8 | 0.8 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | 0.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 181.4 | 125.2 | 174.9 | 171.7 | 167.8 | 45.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 132.1 | 49.7 | 47.2 | 40.5 | 53.2 | 6.3 | 2.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 47.3 | 78.2 | 126.5 | 49.2 | 34.4 | 22.2 | 0.7 | 0.3 | 0.5 | 1.2 | 1.7 | 1.2 | 0.6 | 0.2 | 0.0 | 0.0 | |
| Total Long-Term Assets | 532.8 | 1,273.6 | 418.7 | 360.1 | 307.3 | 223.1 | 67.3 | 6.9 | 4.9 | 4.2 | 2.0 | 1.4 | 0.8 | 0.5 | 0.4 | 0.4 | |
| Total Assets | 4,796.6 | 5,987.3 | 4,542.5 | 3,134.3 | 2,850.3 | 2,284.9 | 1,605.6 | 661.7 | 445.0 | 111.2 | 50.3 | 71.1 | 34.5 | 22.9 | 31.9 | 12.3 |
| Long-Term Assets | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | 2-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 45.8 | 43.5 | 36.9 | 0.0 | 22.7 | 0.0 | 14.7 | 0.0 | 16.2 | 14.2 | |
| Goodwill | 0.0 | 0.0 | 9.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 219.0 | 181.4 | 132.3 | 0.0 | 125.2 | 0.0 | 189.9 | 0.0 | 174.9 | 171.3 | |
| Long-Term Investments | 10.7 | 49.7 | 38.6 | 0.0 | 126.3 | 0.0 | 49.9 | 0.0 | 40.5 | 41.4 | |
| Other Long-Term Assets | 170.8 | 78.2 | 140.8 | -2,946.8 | 47.3 | -1,888.9 | 109.1 | -2,021.3 | 49.2 | 38.7 | |
| Total Long-Term Assets | 1,345.9 | 1,273.6 | 532.8 | -2,946.8 | 418.7 | -1,888.9 | 502.3 | -2,021.3 | 360.1 | 319.9 | |
| Total Assets | 7,175.6 | 5,987.3 | 4,796.6 | 0.0 | 4,542.5 | 0.0 | 3,193.8 | 0.0 | 3,134.3 | 3,249.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 280.6 | 482.7 | 245.6 | 188.7 | 208.9 | 206.8 | 95.6 | 6.9 | 18.3 | 4.6 | 2.1 | 2.0 | 1.2 | 1.9 | 0.4 | 1.7 | |
| Short-Term Debt | 5.9 | 6.3 | 4.6 | 3.4 | 3.5 | 3.5 | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.2 | 2.2 | 0.0 | |
| Other Current Liabilities | 199.2 | 144.3 | 168.5 | 110.1 | 88.9 | 72.5 | 0.4 | 36.5 | 0.7 | 8.2 | 2.9 | 4.0 | 2.7 | 1.6 | 1.5 | 0.0 | |
| Current Liabilities | 499.6 | 646.7 | 423.0 | 302.3 | 301.2 | 329.3 | 179.2 | 45.8 | 31.1 | 44.6 | 9.5 | 10.2 | 4.6 | 6.3 | 4.0 | 2.0 |
| Current Liabilities | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | 2-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 852.2 | 482.7 | 280.6 | 0.0 | 245.6 | 0.0 | 195.3 | 0.0 | 188.7 | 167.2 | |
| Short-Term Debt | 7.6 | 6.3 | 5.9 | 0.0 | 4.6 | 0.0 | 3.2 | 0.0 | 3.4 | 3.5 | |
| Other Current Liabilities | 164.0 | 144.3 | 199.2 | 0.0 | 168.5 | 0.0 | 114.7 | 0.0 | 110.1 | 93.9 | |
| Current Liabilities | 1,041.9 | 646.7 | 499.6 | 0.0 | 423.0 | 0.0 | 317.8 | 0.0 | 302.3 | 264.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 28.1 | 31.4 | 15.4 | 9.0 | 8.0 | 6.2 | 5.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 28.1 | 37.7 | 20.0 | 12.4 | 11.5 | 9.7 | 7.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 5.0 | 0.0 | 5.2 | 8.4 | 6.4 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 534.3 | 679.8 | 445.0 | 320.6 | 316.1 | 606.8 | 428.6 | 45.8 | 31.2 | 44.6 | 9.5 | 10.2 | 4.6 | 6.3 | 4.0 | 2.0 |
| Long-Term Liabilities | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | 2-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 35.6 | 31.4 | 28.1 | 0.0 | 15.4 | 0.0 | 8.0 | 0.0 | 9.0 | 6.2 | |
| Capital Leases | 43.2 | 37.7 | 34.0 | 0.0 | 15.4 | 0.0 | 11.2 | 0.0 | 12.4 | 9.7 | |
| Def. Tax Liability | 0.0 | 0.0 | 5.0 | 0.0 | 5.2 | 0.0 | 8.9 | 0.0 | 8.4 | 7.7 | |
| Total Liabilities | 1,079.8 | 679.8 | 534.3 | 0.0 | 445.0 | 0.0 | 335.7 | 0.0 | 320.6 | 279.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 7.1 | 7.2 | 7.1 | 6.6 | 6.2 | 5.9 | 4.8 | 4.1 | 3.9 | 2.1 | 1.7 | 1.9 | 0.6 | 0.4 | 0.4 | 0.2 | |
| Retained Earnings | -2,437.4 | -1,571.8 | -2,404.8 | -2,109.8 | -1,400.2 | -1,059.6 | -372.5 | -194.0 | -120.7 | -76.2 | -55.9 | -43.5 | -35.2 | -25.6 | -12.5 | -8.4 | |
| Comprehensive Income | 945.1 | 66.7 | 72.1 | 607.0 | 465.4 | 200.5 | 79.0 | 35.4 | 14.1 | 7.9 | 5.1 | 2.9 | 2.0 | 1.6 | 0.5 | 0.3 | |
| Total Common Equity | 4,262.2 | 5,498.3 | 4,097.5 | 2,813.7 | 2,534.2 | 1,678.1 | 1,177.0 | 615.9 | 413.8 | 66.7 | 40.8 | 60.9 | 30.0 | 16.7 | 27.9 | 10.2 |
| Total Common Equity | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | 2-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 7.3 | 7.0 | 6.6 | 0.0 | 7.1 | 0.0 | 6.7 | 0.0 | 6.6 | 6.6 | |
| Retained Earnings | -1,157.0 | -1,517.3 | -2,437.4 | 0.0 | -2,404.8 | 0.0 | -2,233.0 | 0.0 | -2,109.8 | -1,836.1 | |
| Comprehensive Income | 78.2 | 66.7 | 945.1 | 3,797.2 | 843.8 | 2,703.4 | 710.1 | 2,593.9 | 607.0 | 527.3 | |
| Total Common Equity | 6,095.8 | 5,307.5 | 4,262.2 | 3,797.2 | 4,097.5 | 2,703.4 | 2,858.1 | 2,593.9 | 2,813.7 | 2,970.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 34.0 | 37.7 | 20.0 | 12.4 | 11.5 | 9.7 | 7.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.2 | 2.2 | 0.0 | |
| Book Value | 4,262.2 | 5,307.5 | 4,097.5 | 2,813.7 | 2,534.2 | 1,678.1 | 1,177.0 | 615.9 | 413.8 | 66.7 | 40.8 | 60.9 | 30.0 | 16.7 | 27.9 | 10.2 |
| Other | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | 2-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 6,095.8 | 5,307.5 | 4,262.2 | 3,797.2 | 4,097.5 | 2,703.4 | 2,858.1 | 2,593.9 | 2,813.7 | 2,970.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -277.2 | 1,296.0 | 833.0 | -425.0 | -720.3 | -348.7 | -513.8 | -200.0 | -93.6 | -27.5 | -22.5 | -17.1 | -13.1 | -8.6 | -13.3 | -4.7 | |
| Depreciation & Amortization | 112.1 | 0.0 | 17.5 | 111.3 | 104.3 | 5.9 | 4.2 | 2.4 | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | |
| Stock-Based Compensation | 335.4 | 0.0 | 235.2 | 233.0 | 157.0 | 179.4 | 103.9 | 44.3 | 21.9 | 5.1 | 3.0 | 2.5 | 1.2 | 0.3 | 1.0 | 0.3 | |
| Change Working Capital | -247.0 | -423.9 | -324.6 | -404.5 | -375.7 | -341.0 | -13.8 | 310.2 | 10.2 | -22.0 | 32.0 | -0.8 | 5.4 | -0.3 | 0.9 | 0.2 | |
| Change In Accounts Receivable | -215.3 | -804.8 | -422.4 | -186.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 172.9 | 614.2 | 245.9 | 95.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | -126.5 | -99.3 | -95.8 | -83.0 | -119.3 | -83.9 | -25.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 486.9 | -21.6 | -843.9 | 97.7 | -28.1 | -75.0 | -6.5 | -6.2 | -0.7 | 0.0 | -1.7 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | |
| Cash from Operations | -145.5 | 0.0 | 0.0 | -420.3 | -862.8 | -606.8 | -426.0 | 150.8 | -61.6 | -43.8 | 11.1 | -15.2 | -6.4 | -8.4 | -11.1 | -4.0 |
| Cash Flow From Operating Activities | 4-2025 | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 874.9 | 418.1 | 865.6 | -32.5 | -61.6 | -172.1 | -72.6 | -123.4 | -28.9 | 164.0 | |
| Depreciation & Amortization | 0.0 | 13.4 | 8.9 | 8.6 | 0.0 | 103.5 | 0.0 | 4.6 | 0.0 | 99.7 | |
| Stock-Based Compensation | 0.0 | 0.0 | 128.2 | 103.0 | 0.0 | 233.0 | 0.0 | 102.1 | 0.0 | 156.5 | |
| Change Working Capital | -292.3 | -129.2 | -393.9 | -177.6 | 0.0 | -146.2 | 0.0 | -163.1 | 0.0 | -2.9 | |
| Change In Accounts Receivable | -437.7 | -362.5 | -325.5 | -97.6 | 0.0 | -117.8 | 0.0 | -68.2 | 0.0 | 0.0 | |
| Change In Accounts Payable | 248.3 | 362.4 | 0.0 | 0.0 | 0.0 | 96.4 | 0.0 | -0.6 | 0.0 | 0.0 | |
| Change In Inventories | -134.0 | 35.3 | -79.9 | -16.1 | 0.0 | -110.4 | 0.0 | 27.3 | 0.0 | -119.3 | |
| Other Non-cash Items | -174.8 | 135.5 | -566.9 | -26.1 | 61.6 | 484.1 | 72.6 | 74.2 | 28.9 | -1,252.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -69.6 | 0.0 | -258.5 | 0.0 | -834.9 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -65.7 | -112.0 | -1.8 | -0.8 | -103.8 | -121.4 | -5.5 | -46.8 | -0.8 | -0.4 | -0.9 | -0.3 | -0.2 | -0.1 | -0.1 | -0.3 | |
| Acquisitions | 0.0 | 0.0 | -7.0 | 0.0 | -2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -2,112.6 | -1,459.9 | -2,183.5 | -1,271.7 | -1,694.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 1,332.2 | 2,395.8 | 1,429.6 | 1,544.0 | 1,325.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 36.8 | 13.1 | -225.6 | 387.1 | -787.0 | -122.2 | -194.0 | 0.1 | 18.7 | -28.2 | 0.3 | 0.5 | 0.2 | |
| Cash from Investing | -846.1 | 0.0 | 0.0 | 308.2 | -461.2 | -347.1 | 381.6 | -833.8 | -123.0 | -194.4 | -0.8 | 18.4 | -28.4 | 0.2 | 0.3 | -0.1 |
| Cash Flow From Investing Activities | 4-2025 | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -61.9 | -49.4 | -1.0 | -22.3 | 0.0 | -43.4 | 0.0 | -0.5 | 0.0 | -0.8 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -327.3 | -1,124.4 | 0.0 | -1,106.7 | 0.0 | -1,006.0 | 0.0 | -280.7 | 0.0 | -1,694.0 | |
| Sales of Investment | 1,218.7 | 1,163.5 | 0.0 | 567.5 | 0.0 | 764.7 | 0.0 | 781.6 | 0.0 | 1,325.5 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -91.9 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -284.7 | 0.0 | 500.5 | 0.0 | -461.2 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | -3.8 | -4.2 | -3.9 | -2.7 | -1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 22.7 | 37.7 | 17.7 | 11.4 | 5.1 | 5.6 | 5.1 | 8.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.2 | 0.0 | 2.2 | |
| Issuance of Common Stock | 1,336.4 | 0.0 | 0.0 | 1,196.7 | 761.0 | 1,091.3 | 899.8 | 760.5 | 292.5 | 366.3 | 46.9 | 0.3 | 50.7 | 18.4 | 0.0 | 24.9 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -14.8 | 0.0 | 0.0 | 143.8 | 87.0 | 33.9 | 22.9 | -20.4 | -12.6 | 0.0 | 0.0 | 0.0 | -4.8 | 0.0 | 0.0 | -0.3 | |
| Cash from Financing | 1,316.3 | 0.0 | 0.0 | 1,336.7 | 843.8 | 1,121.3 | 919.9 | 738.6 | 279.9 | 366.3 | 46.9 | 0.3 | 45.9 | 18.4 | 0.0 | 24.6 |
| Cash Flow From Financing Activities | 4-2025 | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 0.0 | 43.2 | 37.7 | 34.0 | -20.0 | 20.0 | -11.2 | 11.2 | -12.4 | 12.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,291.0 | 0.0 | 65.2 | 0.0 | 93.2 | |
| Repurchase of Common Stock | 0.0 | -4.5 | -20.1 | -1.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.7 | 0.0 | -2.8 | 0.0 | 750.6 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,276.3 | 0.0 | 62.4 | 0.0 | 843.8 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 327.7 | 1,991.4 | -548.9 | 1,248.1 | -533.9 | 117.9 | 812.2 | 56.3 | 103.1 | 121.1 | 57.2 | 3.6 | 11.5 | 10.1 | -10.7 | 20.5 | |
| Closing Cash Balance | 1,438.2 | 3,491.3 | 1,499.9 | 2,048.8 | 800.7 | 1,334.7 | 1,219.6 | 371.1 | 321.5 | 229.0 | 94.5 | 38.8 | 39.1 | 31.4 | 20.4 | 30.5 |
| Cash position | 4-2025 | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1,405.3 | 586.0 | 61.7 | -610.6 | 0.0 | 938.3 | 0.0 | 263.7 | 0.0 | -452.4 | |
| Closing Cash Balance | 3,491.3 | 2,086.0 | 1,499.9 | 1,438.2 | 0.0 | 2,048.8 | 0.0 | 1,110.6 | 0.0 | -452.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -211.2 | 844.3 | -151.0 | -464.1 | -966.6 | -728.2 | -431.5 | 104.0 | -62.4 | -44.3 | 10.2 | -15.5 | -6.6 | -8.5 | -11.2 | -4.3 | |
| Real Free Cash Flow | -546.6 | 844.3 | -386.2 | -697.1 | -1,123.7 | -907.6 | -535.4 | 59.7 | -84.3 | -49.4 | 7.2 | -18.0 | -7.7 | -8.8 | -12.2 | -4.6 |
| Free Cash Flow | 4-2025 | 2-2025 | 4-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | 4-2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 406.9 | 432.6 | 40.9 | -125.5 | 0.0 | -113.0 | 0.0 | -259.0 | 0.0 | -835.7 | |
| Real Free Cash Flow | 406.9 | 432.6 | -87.3 | -228.5 | 0.0 | -345.9 | 0.0 | -361.1 | 0.0 | -992.2 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 20.4 | -38.3 | -1.4 |
| P/S | 8 | 70.7 | 9.4 |
| P/B | 7.2 | 6.7 | 5.2 |
| P/FCF | 83.9 | -47.5 | -1.5 |
| Market cap | $52.8 | $31.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0.6 % | 0.1 % | 0 % |
| Debt to Income | 2 % | -0.5 % | 0 % |
| Debt to Free cash flow | 8.2 % | -684.6 % | 0 % |
| Interest expense percentage | 0.4 % | 3.9 % | 44.7 % |
| Current ratio | 5.6 | 4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 35.4 % | -8.6 % | 0 % |
| ROA | 30 % | -6.6 % | 0 % |
| CapEx to Revenue | 2 % | 0.8 % | 0 % |
| RaD to Revenue | 0 % | 83 % | 0 % |
| ROEM | 3,434,199.3 | 280291.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 75 % | 45.8 % | 68.7 % |
| Operating margin | 12.9 % | -135.2 % | 35.5 % |
| Net margin | 37.5 % | -141.2 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 65.7 mil | 36.1 mil |
| Employee count | 1.6 tis | 0.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
